TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Nordic Bioscience A/S
Closing information (x1000 DKK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
236,409
|
313,570
|
271,014 |
| Earnings before taxes |
43,008
|
138,108
|
127,490 |
| Total assets |
291,155
|
271,867
|
265,898 |
| Current assets |
204,369
|
187,355
|
188,179 |
| Current liabilities |
186,470
|
155,053
|
101,995 |
| Equity capital |
61,597
|
71,667
|
117,731 |
| - share capital |
10,000
|
10,000
|
10,000 |
| Employees (average) |
150
|
150
|
150 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
21.2%
|
26.4%
|
44.3% |
| Turnover per employee |
1,576
|
2,090
|
1,807 |
| Profit as a percentage of turnover |
18.2%
|
44.0%
|
47.0% |
| Return on assets (ROA) | |||
| Current ratio |
109.6%
|
120.8%
|
184.5% |
| Return on equity (ROE) |
69.8%
|
192.7%
|
108.3% |
| Change turnover |
-77,161
|
42,556
|
271,014 |
| Change turnover % |
-25%
|
16% | |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.